Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine
- PMID: 18953713
- DOI: 10.1515/bc.2008.061
Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine
Abstract
Hepatitis C virus (HCV) causes chronic infection in approximately two-thirds of cases, leading to chronic hepatitis, liver cirrhosis, liver disease, liver failure, and hepatocellular carcinoma in a substantial proportion of the 170 million HCV-infected individuals worldwide. It is generally accepted that the cellular immune response plays the most important role in determining the outcome of HCV infection. First, vigorous, multispecific and sustained CD4+ and CD8+ T-cell responses are associated with viral clearance. Second, depletion studies in chimpanzees, the only other host of HCV besides humans, have shown that both CD4+ and CD8+ T-cells are required for virus elimination. Third, the host's human leukocyte antigen alleles, which restrict the repertoire of CD4+ and CD8+ T-cell responses, influence the outcome of infection. Of note, protective immunity has been demonstrated in population-based studies, as well as in experimentally infected chimpanzees. Thus, a detailed understanding of the mechanisms contributing to the failure of the antiviral immune response should allow successful development of prophylactic and therapeutic vaccination strategies.
Similar articles
-
Success and failure of virus-specific T cell responses in hepatitis C virus infection.Dig Dis. 2011;29(4):416-22. doi: 10.1159/000329807. Epub 2011 Aug 30. Dig Dis. 2011. PMID: 21894013 Review.
-
Immunopathogenesis of hepatitis C virus infection.Clin Liver Dis. 2003 Feb;7(1):89-105. doi: 10.1016/s1089-3261(02)00068-5. Clin Liver Dis. 2003. PMID: 12691460 Review.
-
Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.J Virol. 2015 May;89(10):5478-90. doi: 10.1128/JVI.03717-14. Epub 2015 Mar 4. J Virol. 2015. PMID: 25740982 Free PMC article.
-
Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.J Hepatol. 2011 Jun;54(6):1273-85. doi: 10.1016/j.jhep.2010.09.040. Epub 2011 Jan 12. J Hepatol. 2011. PMID: 21236312 Review.
-
The immunopathogenesis of hepatitis C virus infection.Clin Liver Dis. 2001 Nov;5(4):931-53. doi: 10.1016/s1089-3261(05)70202-6. Clin Liver Dis. 2001. PMID: 11685802 Review.
Cited by
-
Anti-envelope antibody responses in individuals at high risk of hepatitis C virus who resist infection.J Viral Hepat. 2016 Nov;23(11):873-880. doi: 10.1111/jvh.12568. Epub 2016 Jul 13. J Viral Hepat. 2016. PMID: 27405885 Free PMC article.
-
Common threads in persistent viral infections.J Virol. 2010 May;84(9):4116-23. doi: 10.1128/JVI.01905-09. Epub 2009 Dec 2. J Virol. 2010. PMID: 19955304 Free PMC article. Review.
-
Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women.J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):295-303. doi: 10.1097/QAI.0000000000000310. J Acquir Immune Defic Syndr. 2014. PMID: 25314250 Free PMC article.
-
HCV drug discovery aimed at viral eradication.J Viral Hepat. 2010 Feb 1;17(2):77-90. doi: 10.1111/j.1365-2893.2009.01246.x. Epub 2009 Dec 18. J Viral Hepat. 2010. PMID: 20040045 Free PMC article. Review.
-
Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes.J Virol. 2010 Jun;84(11):5751-63. doi: 10.1128/JVI.02200-09. Epub 2010 Mar 31. J Virol. 2010. PMID: 20357091 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials